FIRST AMENDMENT TO THE DISTRIBUTION AND MANUFACTURING SERVICES AGREEMENT BETWEEN LEVPHARMA AND SANQUINManufacturing Services Agreement • March 31st, 2006 • Lev Pharmaceuticals Inc • Pharmaceutical preparations
THIS FIRST AMENDMENT is entered into effective as of the latest of the dates of signatures hereunder by and between the Parties to the DISTRIBUTION AND MANUFACTURING SERVICES AGREEMENT BETWEEN LEVPHARMA AND SANQUIN dated January 16, 2004 (the “AGREEMENT”): LEV PHARMACEUTICALS, INC., a corporation formed under the laws of the state of Delaware, having an address at 236 Old Lancaster Road, Merion Station, Pennsylvania 19066 (“LEVPHARMA”) and the SANQUIN BLOOD SUPPLY FOUNDATION, a not-for-profit organization formed under the laws of The Netherlands, having an address at Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands, acting for the purposes of the AGREEMENT through its Plasma Products Division, (“SANQUIN”).
AMENDMENT NO. 2 TO DISTRIBUTION AND MANUFACTURING SERVICES AGREEMENTServices Agreement • March 31st, 2006 • Lev Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 2 to Distribution and Manufacturing Services Agreement is made as of January 31, 2006 (this “Amendment”) and amends the Distribution and Manufacturing Services Agreement, dated as of January 16, 2004, by and between Lev Development Corp.(formerly known as Lev Pharmaceuticals, Inc.), a Delaware corporation (“LEVPHARMA”), and Sanquin Blood Supply Foundation (“SANQUIN”), a not-for-profit corporation organized under the laws of The Netherlands, as amended by a First Amendment (the “Original Agreement” and together with this Amendment, the “Agreement”). Terms used in this Amendment without definition shall have the meanings given them in the Agreement.
